9 October 2019: Keynote Plenary Discussion this morning at the HiMSS Asia PAC 2019. The topic of discussion was medical service price control with panelist from Thailand, Taiwan,Malaysia and India. The conclusion was it will not be beneficial to the industry and consumers. This is based on some of the results and experiences from countries which had this control for sometime. We have to stay relevant and innovate ways of providing value to the patients.
